A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer’s Disease: A Mini-Review


Fecha de publicación: January 2018

DOI: https://doi.org/10.1159/000485381

Autores: Van Skike C.E., Galvan V. 

Background: Cerebrovascular dysfunction is detected prior to the onset of cognitive and histopathological changes in Alzheimer’s disease (AD). Increasing evidence indicates a critical role of cerebrovascular dysfunction in the initiation and progression of AD. 


Enviar comentario